subject: Aarkstore Enterprise---meridian Bioscience, Inc. (vivo) - Financial And Strategic Analysis Review [print this page] Meridian Bioscience, IncMeridian Bioscience, Inc. (Meridian) is an integrated life science company. It is engaged in the research, development, manufacture, sale and distribution of diagnostic test kits, purified reagents and related products. The company also offers biopharmaceutical enabling technologies. Meridian markets its products to hospitals, veterinary testing centers, reference laboratories, research centers, physician offices and diagnostics manufacturers in more than 60 countries around the world. The company principally operates in the US and Europe through its seven subsidiaries. Its products are marketed and sold through a network of distributors as well as through its direct sales representatives.
Meridian Bioscience, Inc. Key Recent Developments
Apr 20, 2010: Meridian Bioscience Reports Net Earnings Of $5.9 Million In Q2 Fiscal 2010
Mar 23, 2010: Meridian Bioscience Submits illumigene Test To FDA For Marketing Clearance
Jan 21, 2010: Meridian Bioscience Reports Net Earnings Of $8.9 Million In Q1 Fiscal 2010
Nov 12, 2009: Meridian Bioscience Reports Net Earnings Of $32.76 Million In 2009
Nov 12, 2009: Meridian Bioscience Q4 Fiscal 2009 Net Earnings Increases By 16%
This comprehensive SWOT analysis of Meridian Bioscience, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
